Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-06

Clinical Trial Update: Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing CinnaGen-liraglutide to Victoza (liraglutide) for type 2 diabetes, evaluating efficacy and safety; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CinnaGen-liraglutide (liraglutide)
  • Victoza (Liraglutide)

Snippet

Sponsor: Cinnagen | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: UNKNOWN